Pages that link to "Q37874011"
Jump to navigation
Jump to search
The following pages link to Mouse models of graft-versus-host disease: advances and limitations (Q37874011):
Displaying 50 items.
- Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation (Q24626051) (← links)
- Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patients (Q26787230) (← links)
- Graft-versus-host disease: why have we not made more progress? (Q27012940) (← links)
- Nanocomposite treatment reduces disease and lethality in a murine model of acute graft-versus-host disease and preserves anti-tumor effects (Q27310065) (← links)
- The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical Overview (Q28066083) (← links)
- The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease (Q28076264) (← links)
- Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models (Q28085080) (← links)
- How we treat chronic graft-versus-host disease (Q35004923) (← links)
- Human mesenchymal stromal cells attenuate graft-versus-host disease and maintain graft-versus-leukemia activity following experimental allogeneic bone marrow transplantation. (Q35007600) (← links)
- Modified extracorporeal photopheresis with cells from a healthy donor for acute graft-versus-host disease in a mouse model (Q35229872) (← links)
- Recruitment of Donor T Cells to the Eyes During Ocular GVHD in Recipients of MHC-Matched Allogeneic Hematopoietic Stem Cell Transplants (Q35522357) (← links)
- Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation. (Q35692054) (← links)
- Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in Mice (Q35766798) (← links)
- Comparative Analysis of Protocols to Induce Human CD4+Foxp3+ Regulatory T Cells by Combinations of IL-2, TGF-beta, Retinoic Acid, Rapamycin and Butyrate (Q35926395) (← links)
- Immune reconstitution and graft-versus-host reactions in rat models of allogeneic hematopoietic cell transplantation (Q36434639) (← links)
- Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research (Q36579263) (← links)
- Critical differences in hematopoiesis and lymphoid development between humans and mice (Q36788010) (← links)
- Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease. (Q37064425) (← links)
- Potential limitations of the NSG humanized mouse as a model system to optimize engineered human T cell therapy for cancer (Q37233539) (← links)
- Selective blockade of herpesvirus entry mediator-B and T lymphocyte attenuator pathway ameliorates acute graft-versus-host reaction (Q37585824) (← links)
- Reversal of CD8 T-cell-mediated mucocutaneous graft-versus-host-like disease by the JAK inhibitor tofacitinib (Q37652919) (← links)
- Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation (Q37696092) (← links)
- The role of chemokines in mediating graft versus host disease: opportunities for novel therapeutics. (Q37989141) (← links)
- Immune modulation of inflammatory conditions: regulatory T cells for treatment of GvHD. (Q37993738) (← links)
- The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation. (Q38073107) (← links)
- Humanized mouse models in transplantation research (Q38196608) (← links)
- Critical Appraisal of the Utility and Limitations of Animal Models of Scleroderma (Q38681751) (← links)
- B Lymphocyte Chemoattractant (CXCL13) Is an Indicator of Acute Gastrointestinal GVHD in Murine Model. (Q38688669) (← links)
- Pluripotent stem cells progressing to the clinic (Q38747535) (← links)
- Regulatory roles of mast cells in immune responses. (Q38827858) (← links)
- Attenuation of graft-versus-host-disease in NOD scid IL-2Rγ(-/-) (NSG) mice by ex vivo modulation of human CD4(+) T cells. (Q38827908) (← links)
- Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production (Q38932342) (← links)
- Aspergillosis and stem cell transplantation: An overview of experimental pathogenesis studies (Q38968506) (← links)
- Chronic graft-versus-host disease: biological insights from preclinical and clinical studies (Q39002164) (← links)
- Clinical potential of human-induced pluripotent stem cells : Perspectives of induced pluripotent stem cells (Q39024182) (← links)
- Lithothamnion muelleri controls inflammatory responses, target organ injury and lethality associated with graft-versus-host disease in mice. (Q39122603) (← links)
- Unique patterns of CD8+ T-cell-mediated organ damage in the Act-mOVA/OT-I model of acute graft-versus-host disease (Q39802321) (← links)
- The immunosuppressive effect of the tick protein, Salp15, is long-lasting and persists in a murine model of hematopoietic transplant (Q41629882) (← links)
- Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease (Q41896478) (← links)
- CD28 Blockade Ex Vivo Induces Alloantigen-Specific Immune Tolerance but Preserves T-Cell Pathogen Reactivity. (Q41916538) (← links)
- Sphingosine 1-Phosphate Signaling and Its Pharmacological Modulation in Allogeneic Hematopoietic Stem Cell Transplantation. (Q41995676) (← links)
- Risk factors and characterization of vitiligo and alopecia areata in patients with chronic graft-vs-host disease (Q43627667) (← links)
- Effects of exercise interventions in graft-versus-host disease models (Q45324881) (← links)
- Utilizing glycogen synthase kinase-3β as a marker for the diagnosis of graft-versus-host disease (Q45792713) (← links)
- Allogeneic stem cell transplantation in fully MHC-matched Mauritian cynomolgus macaques recapitulates diverse human clinical outcomes (Q45874302) (← links)
- Inhibition of 5-lipoxygenase alleviates graft-versus-host disease. (Q47744316) (← links)
- A20 deletion in T cells modulates acute graft-versus-host disease in mice (Q47917118) (← links)
- Migration and activation of T cells during development of graft-versus-host disease in a mouse model (Q48123946) (← links)
- Optimizing human Treg immunotherapy by Treg subset selection and E-selectin ligand expression (Q49702312) (← links)
- Role of Wild-type and Recombinant Human T-cell Leukemia Viruses in Lymphoproliferative Disease in Humanized NSG Mice (Q49820301) (← links)